Kevin Shee

4.5k total citations · 1 hit paper
56 papers, 2.0k citations indexed

About

Kevin Shee is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Kevin Shee has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Kevin Shee's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers) and Kidney Stones and Urolithiasis Treatments (6 papers). Kevin Shee is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers) and Kidney Stones and Urolithiasis Treatments (6 papers). Kevin Shee collaborates with scholars based in United States, Israel and Argentina. Kevin Shee's co-authors include Ravid Straussman, Todd R. Golub, Teppei Morikawa, Shuji Ogino, Joshua Gould, Dennie T. Frederick, Zhi Rong Qian, Zachary A. Cooper, Roger S. Lo and Michal Barzily-Rokni and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Kevin Shee

49 papers receiving 2.0k citations

Hit Papers

Tumour micro-environment elicits innate resistance to RAF... 2012 2026 2016 2021 2012 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Shee United States 16 1.2k 956 385 312 211 56 2.0k
Stephen Leong United States 23 842 0.7× 1.1k 1.2× 606 1.6× 471 1.5× 106 0.5× 73 2.3k
Muralidhar Beeram United States 27 1.3k 1.1× 1.7k 1.8× 380 1.0× 835 2.7× 141 0.7× 89 3.0k
Kyle D. Holen United States 31 1.1k 1.0× 1.8k 1.9× 372 1.0× 479 1.5× 312 1.5× 126 3.2k
Jane Kendrew United Kingdom 22 1.5k 1.3× 1.1k 1.2× 561 1.5× 638 2.0× 89 0.4× 33 2.7k
Kamila Naxerova United States 18 803 0.7× 760 0.8× 501 1.3× 257 0.8× 146 0.7× 25 1.8k
Colin D. Weekes United States 28 1.4k 1.2× 2.1k 2.2× 758 2.0× 634 2.0× 154 0.7× 144 3.5k
Wen Wee United States 27 742 0.6× 1.1k 1.2× 385 1.0× 393 1.3× 58 0.3× 123 2.0k
Ben Markman Australia 24 1.3k 1.1× 1.2k 1.3× 329 0.9× 489 1.6× 96 0.5× 75 2.5k
Jennifer R. Diamond United States 26 998 0.8× 2.0k 2.1× 469 1.2× 756 2.4× 243 1.2× 136 3.0k
Josef Brueggen Switzerland 10 1.8k 1.6× 633 0.7× 381 1.0× 348 1.1× 125 0.6× 14 2.4k

Countries citing papers authored by Kevin Shee

Since Specialization
Citations

This map shows the geographic impact of Kevin Shee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Shee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Shee more than expected).

Fields of papers citing papers by Kevin Shee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Shee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Shee. The network helps show where Kevin Shee may publish in the future.

Co-authorship network of co-authors of Kevin Shee

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Shee. A scholar is included among the top collaborators of Kevin Shee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Shee. Kevin Shee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shee, Kevin, Janet E. Cowan, Chien‐Kuang Cornelia Ding, et al.. (2025). Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. European Urology Focus. 12(1). 61–69. 2 indexed citations
2.
Shee, Kevin, Janet E. Cowan, Samuel L. Washington, et al.. (2025). Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer. European Urology Focus. 11(6). 869–875.
3.
Shee, Kevin, Heiko Yang, Wilson Sui, et al.. (2024). A Novel Machine-Learning Algorithm to Predict Stone Recurrence with 24-Hour Urine Data. Journal of Endourology. 38(8). 809–816. 7 indexed citations
4.
Shee, Kevin, Heiko Yang, Wilson Sui, et al.. (2023). Voided volume may not impact stone outcomes: Review of a large institutional nephrolithiasis cohort. SHILAP Revista de lepidopterología. 4(5). 556–561. 1 indexed citations
5.
Shee, Kevin, Andy Liu, Heiko Yang, et al.. (2023). PD34-05 A NOVEL MACHINE-LEARNING ALGORITHM TO PREDICT STONE RECURRENCE WITH 24-HOUR URINE DATA. The Journal of Urology. 209(Supplement 4). 1 indexed citations
6.
Shee, Kevin, Albert J. Chang, Anthony Wong, et al.. (2022). Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Advances in Radiation Oncology. 7(5). 100941–100941. 5 indexed citations
7.
Shee, Kevin, Sumanta K. Pal, J. Connor Wells, et al.. (2021). Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer. JCO Clinical Cancer Informatics. 5(5). 912–920. 1 indexed citations
8.
9.
10.
Traphagen, Nicole A., Jennifer Fields, Kevin Shee, et al.. (2020). AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. Clinical Cancer Research. 26(14). 3707–3719. 64 indexed citations
11.
Shee, Kevin, Edward G. Hughes, Sophie J. Deharvengt, et al.. (2020). Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma. Journal of Neuro-Oncology. 148(3). 473–480. 3 indexed citations
12.
Chamberlin, Mary D., Kevin Shee, Jonathan D. Marotti, et al.. (2020). Plasma DNA as a “liquid biopsy” incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer. Breast Cancer Research and Treatment. 182(3). 665–677. 1 indexed citations
13.
Shee, Kevin, Matthew Ung, Nicole A. Traphagen, et al.. (2019). A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. Clinical Cancer Research. 26(1). 159–170. 1 indexed citations
14.
Tse, Dan, Kevin Shee, M. Lakshmi Kuppusamy, et al.. (2019). Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells. Cell Biochemistry and Biophysics. 77(2). 109–119. 13 indexed citations
16.
Shee, Kevin, Kristen E. Muller, Jonathan D. Marotti, et al.. (2018). Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era. American Journal Of Pathology. 189(5). 956–965. 12 indexed citations
17.
Koo, Kevin, Kevin Shee, & E. Ann Gormley. (2018). Following the crowd: patterns of crowdsourcing on Twitter among urologists. World Journal of Urology. 37(3). 567–572. 7 indexed citations
18.
Yang, Wei, Lloye M. Dillon, Kevin Shee, et al.. (2016). Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA -Mutant Breast Cancer. Clinical Cancer Research. 22(9). 2250–2260. 27 indexed citations
19.
Shee, Kevin, Alexandra Lucas, Laura A. Flashman, et al.. (2016). Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury. Neuroscience Letters. 630. 241–246. 5 indexed citations
20.
Owens, Philip, Lloye M. Dillon, Wei Yang, et al.. (2014). The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer. Breast Cancer Research and Treatment. 149(1). 69–79. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026